Unichem Laboratories Limited (BOM:506690)
376.70
-7.75 (-2.02%)
At close: Jan 21, 2026
Unichem Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 22,258 | 21,110 | 17,851 | 13,430 | 12,698 | 12,351 | Upgrade | |
Revenue Growth (YoY) | 25.42% | 18.25% | 32.92% | 5.76% | 2.81% | 11.91% | Upgrade |
Cost of Revenue | 10,298 | 9,219 | 7,949 | 6,064 | 4,686 | 4,260 | Upgrade |
Gross Profit | 11,961 | 11,891 | 9,903 | 7,366 | 8,013 | 8,091 | Upgrade |
Selling, General & Admin | 4,243 | 4,208 | 4,263 | 3,690 | 3,468 | 3,113 | Upgrade |
Other Operating Expenses | 5,138 | 5,034 | 4,771 | 4,098 | 3,742 | 4,062 | Upgrade |
Operating Expenses | 10,617 | 10,488 | 10,265 | 8,922 | 8,122 | 8,018 | Upgrade |
Operating Income | 1,344 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 | Upgrade |
Interest Expense | -266.6 | -207 | -221.5 | -162.52 | -50.21 | -44 | Upgrade |
Interest & Investment Income | 28.5 | 28.5 | 6.7 | 5.22 | 164.91 | 229.43 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -10.61 | -3.43 | Upgrade |
Currency Exchange Gain (Loss) | 215.6 | 215.6 | 224 | 273.16 | 273.82 | 105.39 | Upgrade |
Other Non Operating Income (Expenses) | 137.2 | 3.7 | -0.9 | -41.33 | -29.37 | 43.45 | Upgrade |
EBT Excluding Unusual Items | 1,459 | 1,444 | -354.5 | -1,481 | 239.53 | 403.6 | Upgrade |
Gain (Loss) on Sale of Investments | 92.6 | 92.6 | 64.7 | 90.49 | -17.49 | 116.42 | Upgrade |
Gain (Loss) on Sale of Assets | 29.4 | 9.5 | 16.3 | 12.83 | -2.34 | -5.23 | Upgrade |
Other Unusual Items | -582.6 | - | -576.1 | -385.66 | - | - | Upgrade |
Pretax Income | 998.1 | 1,546 | -849.6 | -1,764 | 219.69 | 514.79 | Upgrade |
Income Tax Expense | 113.5 | 170.7 | 88 | 258.65 | -110.93 | 171.55 | Upgrade |
Earnings From Continuing Operations | 884.6 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income | 884.6 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income to Common | 884.6 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income Growth | - | - | - | - | -3.68% | - | Upgrade |
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | 70 | Upgrade |
Shares Outstanding (Diluted) | 70 | 71 | 70 | 70 | 71 | 70 | Upgrade |
Shares Change (YoY) | 0.17% | 0.31% | - | -0.25% | 0.25% | 0.01% | Upgrade |
EPS (Basic) | 12.58 | 19.53 | -13.32 | -28.72 | 4.70 | 4.88 | Upgrade |
EPS (Diluted) | 12.55 | 19.47 | -13.32 | -28.72 | 4.68 | 4.88 | Upgrade |
EPS Growth | - | - | - | - | -4.01% | - | Upgrade |
Free Cash Flow | -1,049 | -1,444 | -85.5 | -1,294 | -3,866 | -2,548 | Upgrade |
Free Cash Flow Per Share | -14.88 | -20.44 | -1.21 | -18.38 | -54.78 | -36.20 | Upgrade |
Dividend Per Share | - | - | - | - | 4.000 | 4.000 | Upgrade |
Gross Margin | 53.73% | 56.33% | 55.47% | 54.85% | 63.10% | 65.51% | Upgrade |
Operating Margin | 6.04% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% | Upgrade |
Profit Margin | 3.97% | 6.51% | -5.25% | -15.06% | 2.60% | 2.78% | Upgrade |
Free Cash Flow Margin | -4.71% | -6.84% | -0.48% | -9.63% | -30.45% | -20.63% | Upgrade |
EBITDA | 2,507 | 2,577 | 810.7 | -480.19 | 747.05 | 838.59 | Upgrade |
EBITDA Margin | 11.26% | 12.21% | 4.54% | -3.57% | 5.88% | 6.79% | Upgrade |
D&A For EBITDA | 1,163 | 1,174 | 1,174 | 1,076 | 856.06 | 765.83 | Upgrade |
EBIT | 1,344 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 | Upgrade |
EBIT Margin | 6.04% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% | Upgrade |
Effective Tax Rate | 11.37% | 11.04% | - | - | - | 33.32% | Upgrade |
Revenue as Reported | 22,765 | 21,463 | 18,167 | 13,815 | 13,173 | 12,853 | Upgrade |
Advertising Expenses | - | 168.2 | 215.2 | 117.46 | 144.12 | 26.81 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.